ZA761306B - Pge-type prostaglandin compositions - Google Patents

Pge-type prostaglandin compositions

Info

Publication number
ZA761306B
ZA761306B ZA761306A ZA761306A ZA761306B ZA 761306 B ZA761306 B ZA 761306B ZA 761306 A ZA761306 A ZA 761306A ZA 761306 A ZA761306 A ZA 761306A ZA 761306 B ZA761306 B ZA 761306B
Authority
ZA
South Africa
Prior art keywords
pge
type prostaglandin
prostaglandin compositions
compositions
type
Prior art date
Application number
ZA761306A
Other languages
English (en)
Inventor
S Yalkowsky
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA761306B publication Critical patent/ZA761306B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA761306A 1975-03-27 1976-03-04 Pge-type prostaglandin compositions ZA761306B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/562,535 US3966962A (en) 1975-03-27 1975-03-27 Triacetin solutions of PGE-type compounds

Publications (1)

Publication Number Publication Date
ZA761306B true ZA761306B (en) 1977-02-23

Family

ID=24246672

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA761306A ZA761306B (en) 1975-03-27 1976-03-04 Pge-type prostaglandin compositions

Country Status (11)

Country Link
US (1) US3966962A (enExample)
JP (1) JPS6020365B2 (enExample)
BE (1) BE840075A (enExample)
CA (1) CA1044140A (enExample)
DE (1) DE2611183C2 (enExample)
FR (1) FR2305177A1 (enExample)
GB (1) GB1493092A (enExample)
HK (1) HK10481A (enExample)
MX (1) MX3794E (enExample)
NL (1) NL190539C (enExample)
ZA (1) ZA761306B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU510190B2 (en) * 1976-08-14 1980-06-12 Carlson, Lars A Prostaglandin method
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA835226B (en) * 1982-07-19 1985-03-27 Syntex Inc Pge-type compositions encapsulated by acid isolated gelatin
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures
US4955878A (en) * 1986-04-04 1990-09-11 Biotechnology, Inc. Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
JP3756512B2 (ja) * 1992-09-21 2006-03-15 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 徐放性タンパク質製剤
BRPI0014869B8 (pt) * 1999-10-15 2021-05-25 Sucampo Ag prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
US20100286101A1 (en) * 2009-05-07 2010-11-11 Jason Carbol Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability
WO2015200444A1 (en) * 2014-06-24 2015-12-30 Saudi Arabian Oil Company Encapsulation of an acid precursor for oil field applications
US20230338322A1 (en) * 2020-05-04 2023-10-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Glyceryltriacetate (gta) for use in improving breathing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA721937B (en) * 1971-10-22 1972-12-27 Upjohn Co Pharmaceutical preparations and uses thereof
US3829579A (en) * 1971-11-01 1974-08-13 Upjohn Co Stable solutions of pge-type compounds
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same
JPS5729463B2 (enExample) * 1973-12-07 1982-06-23

Also Published As

Publication number Publication date
NL190539C (nl) 1994-04-18
JPS6020365B2 (ja) 1985-05-21
DE2611183C2 (de) 1985-08-14
DE2611183A1 (de) 1976-10-14
FR2305177A1 (fr) 1976-10-22
FR2305177B1 (enExample) 1982-10-08
CA1044140A (en) 1978-12-12
HK10481A (en) 1981-03-27
NL7603064A (nl) 1976-09-29
AU1194876A (en) 1977-09-15
BE840075A (fr) 1976-09-27
MX3794E (es) 1981-07-22
JPS51112508A (en) 1976-10-05
NL190539B (nl) 1993-11-16
GB1493092A (en) 1977-11-23
US3966962A (en) 1976-06-29

Similar Documents

Publication Publication Date Title
JPS51150560A (en) Filmmforming compositions
JPS51150561A (en) Filmmforming compositions
ZA76830B (en) Prostaglandin analogues
GB1554023A (en) Compositions containing prostaglandin lactones
ZA761306B (en) Pge-type prostaglandin compositions
GB1540483A (en) Prostaglandin containing compositions
GB1538554A (en) Hydrocurable compositions
ZA767416B (en) Prostaglandin analogs
AU502427B2 (en) Prostaglandin analogs
GB1548675A (en) Odiurant compositions
ZA752304B (en) Prostaglandin compositions
GB1549326A (en) Sunprotective compositions
ZM6876A1 (en) Match-head compositions
ZA76512B (en) Prostaglandin analogs
JPS5232924A (en) Soluvent compositions
IL48870A0 (en) Prostaglandin analogues
ZA764484B (en) Improved emulsifier compositions
JPS5271552A (en) Compositions
ZA7692B (en) Prostaglandin analogs
PT64948A (en) Compositions
HK7081A (en) Prostaglandin analogues
JPS51116848A (en) Moistrueeprevnting compositions
AU498923B2 (en) 11-oxy-213 prostaglandin 9-ketals
GB1554026A (en) Prostaglandin lactones
AU1409976A (en) Prostaglandin analogues